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Abstract 
Background: To compare the frequency of 
chlamydia trachomatis infection in women with 
ectopic and with normal pregnancies. 
Methods: In this case-control study diagnosed 
patients of ectopic pregnancy(EP)were included . 
The control group comprised of early normal intra 
uterine pregnancies (1st trimester). A total number of 
88, comprising 44 cases and 44 controls were 
included in this study. Sera from patients was drawn 
at the time of operation or within the subsequent 24 
hours. Anti-chlamydial IgG was performed by 
ELISA. 
Results: Sampled cases population (n=44) had 
mean age distribution 26.48 years while among 
controls, mean age was 25.32 years. Presenting 
symptoms of cases showed pelvic pain (54.5%), 
bleeding (27.3%), vomiting (11.4%) and burning 
micturition (6.8%). During contraceptive practices , 
out of 88 patients, 5 cases and 20 controls gave 
history of safe sex practices.  Out of  63 patients, who 
did not give history of any contraceptive practice, 
Anti-Chlamydia IgG was detected in 11 cases and 5 
controls. Regarding Anti-Chlamydia IgG 
distribution among cases and controls, IgG was 
detected in 11(25%) cases and in 5(11.3%) controls. 
Conclusion: Frequency of anti-chlamydial IgG 
antibodies was much higher in women with ectopic 
pregnancy (25%) as compared to healthy 
controls(11.3%). 
Key Words: Ectopic pregnancy, ELISA, Enzyme 
linked immunosorbant assay, Anti-Chlamydia IgG 
Introduction 
Ectopic pregnancy is pregnancy production outside 
the uterine cavity, with more than 98% of the implant 
in the fallopian tube. Tubal ectopic pregnancy is the 
most common reason for maternal mortality in the first 
three months of pregnancy especially in developing 
countries. The main risk factors for tubal ectopic 
pregnancy  are damage to the tubes from surgery or 
injury, smoking, in vitro fertilization and Chlamydia 
trachomatis infection. 1,2 
The main risk for tubal ectopic pregnancy factors are 
damage to the tubes from surgery or injury, smoking 
and in vitro fertilization.3 Another important postulate 
for underlying cause of ectopic tubal may be the idea 
of change in transport media and environment of 
fallopian tubes leading  to retention of the fetus.4 
Chlamydia infection is the most common sexually 
transmitted bacterial infection in the world, and it is 
highest in adolescents and young adults.5 Chlamydia 
trachomatis is an obligate intracellular Gram negative 
pathogens and the majority of infections are 
asymptomatic, and thus continues to be diagnosed in 
substantial proportion of the infected individuals who 
may develop complications. Untreated cases of 
Chlamydial infection can also cause chronic pelvic 
pain in women. Ectopic pregnancy (EP), infertility and 
pelvic inflammatory disease (PID) are also caused by 
chlamydial infections.6Chlamydia trachomatis passed 
during childbirth may cause neonatal conjunctivitis 
and pneumonia.7,8 Chlamydia infection also leads to 
the continuous transmission of  infection to and fro in 
sexual partners and thus causing chronicity. Pelvic 
inflammatory disease is usually the ultimate outcome.6 
Inflammation ascends from the cervix of the infected 
female to the peritoneal cavity.9-11  Several case- 
control studies and group analysis concluded that 
ectopic pregnancies are due to the sequelae of 
Chlamydia trachomatis salpingitis.12 Despite the strong 
epidemiological, serological and histological 
associations between upper genital Chlamydia 
infection and subsequent ectopic pregnancy and 
fallopian infertility , the pathogenic mechanism 
leading to tubal damage still needs to be determined.10 
The appearance of plasma cell salpingitis has a strong 
commitment to women with ectopic pregnancy with 
anti-chlamydial IgG positive. Histopathologic findings 
of tubal tissue of Chlamydia trachomatis associated 
ectopic pregnancy shows plasma cell infiltration in 
lamina propria and submucosa.13 
Journal of Rawalpindi Medical College (JRMC); 2017;21(3): 215-218 
 216 
Persistent infection and re-infection with C. 
trachomatis is linked to a deterioration in the long pass 
complications.14 Capacity to form Elementry body(EB) 
and Reticulate body (RB) during  replication cycle  
improves survival of organisms in the genital tract. 15 
The EB and C. trachomatis adheres to the epithelial 
cell surface and incorporated into phagosomes, which 
migrate to the distal region of golgi complex and 
prevent lysosome fusion to chlamydia infection and 
contact immediate destruction.16 The infectious 
particles stability in humans, suggest that persistent 
infection may remain undetected for many years. 
Once the fallopian tube epithelial cells are infected, 
degeneration and damage of inflammation along the 
tube steps in fallopian tube .Agglutination aggravates 
edema and inflammation of the endometrium trumpet. 
It leads to trumpet clubbing and pili partial or 
complete obstruction of the cavity. Peritonitis caused 
by Chlamydia trachomatis, which can affect the 
uterus, fallopian tubes causes fibrin exudation on the 
surface of the ovary. Often these adhesions are 
associated with chronic pelvic pain. Subsequent 
episodes of PID doubles the risk of ectopic pregnancy 
and infertility. 17-19 
Chlamydia antibodies testing has been incorporated 
on large scale for workup of infertility and has proven 
to be a non-invasive examination and effective way in 
terms of the cost.20 Other modalities include 
Hysterosalpingogram (HSG) and Laparoscopy. HSG is 
not cost effective and laparoscopy is an invasive 
procedure. Despite of the clinical significance of the 
test for chlamydia antibodies, it has its limits, because 
of false negative and false positive results of the tests.21 
As a cause of false negative chlamydia antibody tests, 
it has been assumed that IgG antibodies may be 
reduced with the passage of time after C. Trachomatis 
infection, in light of the time period between initial 
infection in adolescence and fertility work -up in 
adulthood.  
Patients and Methods 
This was a case-control study conducted in Pathology 
Department, Holy Family Hospital. This study was 
conducted in a period of six months from June 2014 to 
November 2014. A total number of 88, comprising 44 
cases and 44 controls were included in this study. 
Simple random sampling was done. Control group 
comprised of early normal intra uterine pregnancies 
(1st trimester). The diagnosis of ectopic pregnancy was 
confirmed on ultrasound. Women using an 
intrauterine contraceptive device (IUCD) at the time of 
conception and women with prior tubal surgery 
including tubal ligation were excluded from the study. 
After taking informed consent both cases and controls 
were interviewed using a questionnaire for age, socio-
demographic characteristics, medical and obstetric 
histories. The patients' blood was collected for the 
detection of Anti-Chlamydia IgG.All sera aliquots 
were kept at –20°C till evaluation for anti-chlamydial 
IgG . Positive and negative controls served as internal 
controls for the reliability of the test procedure were 
analyzed with each test. 
Results 
Age distribution  of sampled population (n=88)ranged 
from 19 to 38 years, with a mean age  of  25.90 years  ± 
3.91.  Sampled population was divided into four age 
groups. Age group ranging from 19 to 24 years had 12 
(27.3%)  cases and 20 (45.5%) controls. Age group 
ranging from 25-29 years had frequency of cases 23 
(52.3%) and of controls 15 (34.1%). Using chi square 
test, p value was non-significant (p value=0.91) 
showing equal age distribution among cases and 
controls (Table 1).  
Table 1: Age distribution of cases  and controls  
Group Cases No(%) Controls N0(%) 
19-24 Years 12 (27.3%) 20(45.5%) 
25-29 Years 23 (52.3%) 15(34.1%) 
30-34 Years 8 (18.2%) 7(15.9%) 
>35 Years  1(2.3%) 2(4.5%) 
Total 44 (100.0%) 44 (100.0%) 
Using chi square test, p value = 0.91 (non-significant) 
Table 2: Presenting complaints in patients with 
positive anti-chlamydial antibodies 
Presenting complaint No(%) 
Pelvic pain 24(54.5) 
Bleeding 12(27.3) 
Burning micturition 3(6.80 
Vomiting 5911.4) 
Table 3: Parity Status distribution of cases 
(n=44) and controls (n=44) 
 
Parity Cases No(%)  Controls No(%) 
Primigravida 4 9.1 17 38.6 
Multigravida 40 90.9 27 61.4 
Total 44 100.0 44 100.0 
Using chi square test, p value = 0.001 (Significant) 
 
Frequency of illiterate cases was 27.2%. Pelvic pain 
(54.5%) was the commonest complaint (Table 2).  In 
patients’ group multigravida ware commonest 
40(90.9%) and among controls  27(61.4%) were 
multigravida  (Table 3).Regarding Anti-Chlamydia 
IgG distribution among cases and controls, IgG was 
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detected in 11(25%) cases and in 5(11.3%) controls. The 
difference was statistically non-significant at present 
sample size. (Table 4) 
 
Table 4: Anti-Chlamydia IgG Status of cases  
and controls  
Anti-
Chlamydi
a IgG 
Case  
Frequency 
(Percentage) 
Control Frequency 
(Percentage) 
Present 11% 25% 5 11.3% 
Absent 33% 75% 39 88.7% 
Total 44% 100% 44 100% 
Using Pearson Chi-Square test p value = 0.097;Odds ratio = 
0.385 (95% Confidence Interval 0.121 to 1.220) 
Table 5: Cross tabulation between parity & 
presence of Anti-Chlamydia IgG among cases & 
controls 
Parity Group Total 
Case Control 
Primigravida Anti-
Chlamydia 
IgG 
Absent 4 16 20 
Present 0 1 1 
Total 4 17 21 
Multigravida Anti-
Chlamydia 
IgG 
Absent 29 23 52 
Present 11 4 15 
Total 40 27 67 
Using Pearson Chi-Square test p value = 0.1 (non-significant) 
 
Table 6: Absence of Safe Sex Practice and Anti-
Chlamydia IgG among cases and controls  
Practice of Safe Sex Group Total 
Case Control 
No Anti-
Chlamydia 
IgG 
Absent 28 19 47 
Present 11 5 16 
Total 39 24 63 
Using Pearson Chi-Square test p value = 0.514;Odds ratio = 
0.67 (95% Confidence Interval 0.2 to 2.24) 
 
On cross tabulation, between parity and anti-
Chlamydia IgG among cases and controls, out of 21 
primigravida  among control group, anti-Chlamydia 
IgG was present only in 1. While out of 67 
multigravida patients, 11 among cases and 4 among 
control group were positive for anti-Chlamydia  IgG. 
When chi-square test was applied, p value came out 
0.1 i.e. non-significant. (Table 5). On cross tabulation, 
safe sex practices among cases and controls, out of 88 
patients, 5 cases and 20 controls gave history of  safe 
sex practices. When we cross tabulated absence of safe 
sex practices and anti-Chlamydia IgG among cases 
and controls, out of 63 eligible sampled population 
Anti-Chlamydia IgG was detected in 11 cases and 5 
controls (Table 6) 
Discussion 
Chlamydia trachomatis is a silent infection and 
remains asymptomatic in majority. It is associated with 
ectopic pregnancy with a varying degree in different 
populations. This association is much related with 
sexual practices behaviour of the target population. In 
developing world, prevalence of Chlamydia 
trachomatis is supposedly increasing secondary to 
change in lifestyles, family traditions and western style 
of living. In present prevalence of Anti-Chlamydia IgG 
i.e. infection with Chlamydia trachomatis is high in 
women with ectopic pregnancy as compared to 
healthy controls. The total frequency of Chlamydia 
trachomatis is quite in excess as presented by other 
studies. In another Pakistani study, infection rate was 
reported 4% in women presenting to obstetric 
department of a tertiary care hospital of Khyber 
Pukhtunkhwa.22 The reason behind this difference may 
be sampling technique implied in our and the 
discussed study. Similarly an Indian study has shown 
Chlamydia trachomatis infection rate 17.6% in tribal 
women.23 In an observational study of Saudi 
population of pregnant females residing in Makah, 
seropositivity of Chlamydia trachomatis came out 
about 8.7%. 24 
Among cases with ectopic pregnancy, Anti-Chlamydia 
IgG was detected in 25% patients showing a high 
prevalence among cases showing an association with 
early miscarriage. In one of previously elaborated 
study, 7.6% women with Chlamydia trachomatis 
infection were infertile/sub fertile.22 In another study, 
59.1% of sampled population had more than once 
diagnosis of Chlamydia trachomatis infection prior to 
presentation with ectopic pregnancy. This study 
concluded that number of infections with Chlamydia 
trachomatis and its duration is associated with ectopic 
pregnancy.25 
Among healthy pregnant controls, the frequency of 
Chlamydia trachomatis was found high i.e. 11.3%. This 
shows an increasing trend in toll of sexually 
transmitted diseases in our population. In a 
Norwegian study on Pakistani couples, 1% women 
had positive Chlamydia trachomatis (Anti-Chlamydia 
IgG detected) as compared to 12% men with Anti-
Chlamydia IgG.26 
Cases presented with different symptoms. Its 
spectrum may help us stratify the patients with more 
need of screening and treatment.  Pelvic pain was 
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found in 24 (54.5%) patients, bleeding in 12(27.3%), 
vomiting in 5(11.4%) and burning micturition in 
3(6.8%). So we may conclude that the pregnant 
females presenting to antenatal services with above 
nonspecific symptoms should be screened for Anti-
Chlamydia IgG.  Regarding parity distribution of cases 
and controls, primigravida had frequency of 4(9.1%) 
among cases and 17 (38.6%) among controls. While 
cases showed frequency multigravida about 40(90.9%) 
and 27(61.4%) among controls were multigravida. Safe 
Sex practices may play an important role in prevention 
as depicted by data of our study. Safe Sex practices 
among cases was low i.e. 1.1% while45.5% among 
controls. 
Conclusions 
1. Frequency of chlamydia trachomitis as detected by 
positive Anti-Chlamydia IgG infection in women 
with ectopic pregnancies is 25% and with normal 
pregnancies is 11%.Although in present sample 
size the difference is statistically non-significant 
but there is a difference in frequencies of 
Chlamydia trachomatis as detected by positive 
Anti-Chlamydia IgG infection in cases and 
controls. 
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